ZIOPHARM Oncology Inc (NASDAQ:ZIOP)

3.71
Delayed Data
As of 4:00pm ET
 -0.02 / -0.54%
Today’s Change
3.33
Today|||52-Week Range
7.88
-10.39%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Biotechnology
MARKET CAP
$529.5M

Company Description

ZIOPHARM Oncology, Inc. is a biopharmaceutical company, which engages in the development, acquisition, and commercialization of a diverse portfolio of cancer therapies. It focuses on developing products in immuno-oncology that employ novel gene expression, control, and cell technologies for the treatment of cancer and graft-versus-host-disease. The company was founded on September 9, 2003 and is headquartered in Boston, MA.

Contact Information

ZIOPHARM Oncology, Inc.
Parris Building
Boston Massachusetts 02129
P:(617) 259-1970
Investor Relations:

Employees

Shareholders

Individual stakeholders25.79%
Mutual fund holders17.93%
Other institutional15.84%

Top Executives

Laurence James Neil CooperChief Executive Officer
David M. MauneyExecutive VP, Chief Operating & Business Officer
Kevin G. LafondPrincipal Financial Officer & Treasurer
Francois LebelChief Medical Officer, EVP-Research & Development
Caesar J. BelbelSecretary, Chief Legal Officer & Executive VP